Helene Cauwel-Schryve

Director of Biostatistics

Helene Cauwel-Schryve is Director of Biostatistics within the Cytel PBS Biostatistics team. She brings more than 20 years of experience in clinical trials for pharmaceutical companies and CROs, with a strong focus on oncology in phase I to IV. Her responsibilities include statistical input into the development of protocols, statistical analysis plans, statistical analyses, contribution to study reports and submission dossiers, statistical lead activities, and project and people management. Prior to joining Cytel in 2015, Helene served as a Lead Biostatistician at Servier and Novartis Oncology.

Helene Cauwel-Schryve

Related Articles

Master Protocols in Oncology Trials
Blog
September 16, 2025
Master Protocols in Oncology Trials
Read More
The Estimand Framework in Oncology Trials
Blog
September 4, 2025
The Estimand Framework in Oncology Trials
Read More
Blinded Independent Central Review in Oncology Trials: Key Challenges
Blog
August 26, 2025
Blinded Independent Central Review in Oncology Trials: Key Challenges
Read More